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B cell receptor signaling and downstream NF-κB activity are crucial
for the maturation and functionality of all major B cell subsets, yet
the molecular players in these signaling events are not fully un-
derstood. Here we use several genetically modified mouse models
to demonstrate that expression of the multifunctional BRCT
(BRCA1 C-terminal) domain-containing PTIP (Pax transactivation
domain-interacting protein) chromatin regulator is controlled by
B cell activation and potentiates steady-state and postimmune
antibody production in vivo. By examining the effects of PTIP de-
ficiency in mice at various ages during ontogeny, we demonstrate
that PTIP promotes bone marrow B cell development as well as the
neonatal establishment and subsequent long-term maintenance of
self-reactive B-1 B cells. Furthermore, we find that PTIP is required
for B cell receptor- and T:B interaction-induced proliferation, dif-
ferentiation of follicular B cells during germinal center formation,
and normal signaling through the classical NF-κB pathway. To-
gether with the previously identified role for PTIP in promoting
sterile transcription at the Igh locus, the present results establish
PTIP as a licensing factor for humoral immunity that acts at several
junctures of B lineage maturation and effector cell differentiation
by controlling B cell activation.
antibody | B cell biology | B-1 | IgM | immunodeficiency
The full spectrum of vertebrate humoral antibody immunity ismade up of natural antibodies and postimmune antigen-
specific antibodies (1). Natural antibodies are produced by
innate-like B-1 cells enriched for reactivities to carbohydrate
moieties found on common microbial pathogens as well as self-
glycolipids and play an established role in immune surveillance
and the clearance of cellular debris (2). Together with marginal
zone (MZ) B cells, B-1 cells also mount rapid thymus-independent
(TI) antibody responses against blood-borne pathogens and provide
an important first line of defense during early stages of infection (3,
4). The far more prevalent follicular (FO) B-2 B cell subset, on the
contrary, undergoes T-dependent (TD) affinity maturation and
antibody class-switch recombination (CSR) in germinal centers
(GCs) of secondary lymphoid organs to provide high-affinity IgG
responses during the later stages of infection as well as immuno-
logical memory. Together, the different B cell subsets perform
nonredundant functions to provide optimal host defense.
The PTIP protein is a ubiquitously expressed, nuclear-localized
chromatin regulator containing six BRCT (BRCA1 C-terminal) do-
mains. It has been described as an adaptor protein and is implicated
in gene regulation, DNA replication, and DNA repair (5). Even
though PTIP associates with the MLL3/MLL4 methyltransferase
complex, it also has the capacity to function in gene expression in-
dependently from this complex (6) and in DNA repair with the
53BP1 protein (7). In B cells, PTIP is required for sterile transcrip-
tion of switch regions at the Ig heavy-chain (Igh) locus and sub-
sequent IgH CSR to multiple IgG isotypes in a manner independent
from MLL3/MLL4 (6, 8, 9). Here we use mouse genetics to dem-
onstrate that PTIP additionally establishes steady-state and post-
immune IgM and IgG antibody production in vivo by regulating the
development, activation, and survival of B cell subsets, at least in part,
via the classical NF-κB signaling pathway.
Results
PTIP Is Required for Antibody Production in Vivo. PTIP is known to
facilitate IgH class-switching in stimulated B cells ex vivo (6,
8). To begin to determine the role of PTIP in antibody re-
sponses in vivo, we immunized CD19cre/+PTIPflox/flox (referred
to here as PTIP−/−) mice and assayed antigen-specific antibody
levels from serum over a 3-wk period. We used TNP-LPS as a
TI type 1 antigen, TNP-Ficoll as a TI type 2 antigen, and TNP-
KLH as a TD antigen. Serum from PTIP−/− mice harbored a
near-complete block in the levels of TNP-specific IgG3 after
immunization compared with CD19cre/+PTIP+/+ controls (re-
ferred to as WT) at 7 d postimmunization (Fig. 1 A–C, Right),
in line with previous ex vivo findings (6, 8). IgG1 and IgG2b
responses were similarly altered in PTIP−/− mice (Fig. S1 A–C).
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Interestingly, PTIP−/− mice showed impaired levels of TNP-
specific IgM across the three different immunization schemes,
ranging from 2.8- to 14-fold decreases at 7 d postimmunization,
suggesting a physiological role beyond regulation of CSR (Fig.
1 A–C, Left). We conclude that PTIP promotes antigen-
specific IgM and IgG responses in vivo, despite being largely
dispensable for the development of most splenic B cells (8)
(Fig. S1D).
In view of the profound impairments in antibody responses to
TI and TD antigens in PTIP-deficient mice, we examined GC
formation in these mice. Mice were immunized with the TD
antigen sheep red blood cells (SRBCs) and GC B cells were
assayed from spleens. At 6 and 10 d postimmunization, PTIP−/−
mice displayed severely impaired frequencies and numbers of
GC (CD19+B220+PNA+CD95+) B cells compared with control
mice (Fig. 1 D and E). Consistent with IgG1 class-switching
defects associated with PTIP deficiency (6, 8) (Fig. S1 A–C),
IgG1+ frequencies were also impaired among GC B cells in
SRBC-immunized PTIP−/− mice compared with controls (Fig. 1F
and Fig. S1E). We conclude that PTIP promotes TD GC B cell
differentiation after immunization in vivo.
To determine antibody levels at steady state, we analyzed se-
rum from unimmunized animals. We found that PTIP−/− mice
displayed a 7.6-fold decrease in serum IgM levels in addition to
severely reduced IgG1, IgG2a, IgG2b, and IgG3 levels (Fig. 1G).
At steady state, IgM antibodies are highly enriched for speci-
ficities against carbohydrate moieties such as phosphorylcholine
(PC) and serve an important function in immune surveillance
and the removal of cellular debris (2). To determine whether the
decrease in steady-state serum IgM levels from PTIP−/−mice was
linked to a deficiency in such protective natural antibodies, we
measured PC-specific IgM titers and observed a 10-fold decrease
(Fig. 1G). Thus, PTIP critically potentiates steady-state and
postimmune levels of IgM and IgG antibodies in vivo.
PTIP harbors DNA repair functions that are, at least in part,
mediated by its physical association with 53BP1 (7); however,
consistent with other reports (10, 11), we found decreased
IgG1 but normal total IgM in the serum of 53BP1−/− mice (Fig.
1H). In addition, PC-specific IgM levels from 53BP1−/− mice
were indistinguishable from those from controls (Fig. 1H). Fur-
thermore, even though antigen-specific IgG3 levels were severely
impaired upon challenging 53BP1−/− mice with the TI type 2
TNP-Ficoll antigen, we found antigen-specific IgM to be in-
distinguishable vs. controls (Fig. S1F). These results suggest that
PTIP promotes natural and antigen-induced IgM levels in-
dependently from its association with 53BP1 and its involvement
in DNA repair.
PTIP Deficiency Causes a Partial Block in B Cell Development. To
begin to investigate the underlying cause for such profound im-
munodeficiency, we analyzed the B cell compartments in un-
perturbed PTIP−/− mice. Bone marrow from PTIP−/− and control
mice was first analyzed to ascertain whether loss of PTIP affects
B cell development. Although no differences were observed in
pro-B (CD93+B220+CD19+IgM−CD43+CD24med) cells, num-
bers of small pre-B (CD93+B220+CD19+IgM−CD43−CD24+)
cells were decreased 2.2-fold in PTIP−/− bone marrow compared
with controls, along with a subtle 1.4-fold decrease in immature
(CD93+B220+CD19+IgM+CD24+) B cells (Fig. 2 A and B).
Numbers of large pre-B (CD93+B220+CD19+IgM−CD43+CD24hi)
cells and mature (CD93−B220+CD19+IgM+CD24−) B cells in
the bone marrow were concomitantly increased 1.9-fold and
1.5-fold, respectively, comparable to controls (Fig. 2 A and B).
We conclude that loss of PTIP leads to a mild B cell develop-
ment defect marked by an inefficient transition of large cycling
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Fig. 1. PTIP is required for steady-state and antigen-
induced antibody production in vivo. Mice were immu-
nized with (A) TNP-LPS, (B) TNP-Ficoll, or (C) TNP-KLH,
and anti-TNP-specific IgM or IgG3 serum levels were
measured by ELISA at the indicated days before and after
immunization. Data are from four mice of each geno-
type in A, four mice in B, and seven mice in C, and are
plotted as Ig concentration or the absorbance for the
serum dilution that gave half optical density (mean ±
SEM). Experiments were repeated at least two times.
P values at 7 d after immunization are as follows: (A) IgM,
*P = 0.03; IgG3, ****P < 0.0001; (B) IgM, *P = 0.02; IgG3,
***P = 0.0003; (C) IgM, ***P = 0.001; IgG3, ****P <
0.0001. (D) Flow cytometric analysis of GC B cells in the
spleen at the indicated days after immunization with
SRBCs. (E) GC B cell numbers (Top) and frequencies
(Bottom) from spleens (as inD) of at least threemicewith
PBS, five mice at 6 d, and nine mice at 10 d per genotype
postimmunization. Data are presented as mean ± SEM.
(Top) Day 6, *P = 0.02; day 10, **P = 0.003; PBS vs. day
6 in WT, **P = 0.001. (Bottom) Day 6, ****P < 0.0001;
day 10, **P = 0.002; PBS vs. day 6 inWT, ****P < 0.0001.
(F) Flow cytometric analyses of IgG1+ frequencies among
GC B cells as in D. Data are presented as mean ± SEM.
Day 6, ***P = 0.0005; day 10, ****P < 0.0001; PBS vs. day
6 in WT, ****P < 0.0001. (G) ELISA analysis of total Ig
levels from sera of unimmunized mice. Data are from at
least six mice of each genotype and are presented as
mean ± SEM. IgG1, *P = 0.015; IgG2a, ***P = 0.001;
IgG2b, **P = 0.005; IgG3, **P = 0.004; IgM, **P = 0.002;
anti-PC IgM, ***P = 0.0006. (H) ELISA analysis of total Ig
levels from sera of unimmunized mice. Data are from at
least six mice of each genotype and are presented as
mean ± SEM. IgG1, *P = 0.046; others not significant (ns).
Statistics were generated by using a two-tailed unpaired
t test with Welch’s correction.
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Fig. 2. PTIP deficiency causes a partial block in B cell development and impairs establishment of innate-like B cell subsets. (A) Flow cytometric analysis of bone
marrow cells from adult mice. (B) Numbers of developing B cells from bone marrow of at least eight mice per genotype. Data are presented as mean ± SEM.
Large pre-B, *P = 0.02; small pre-B, ***P = 0.0006; immature B, *P = 0.05; mature B, *P = 0.03; pro-B, P = 0.08 [not significant (ns)]. (C–E) Flow cytometric
analyses of splenic B cells from adult mice. (D) B cell numbers from spleens as in C and E from at least 13 mice. Data are presented as mean ± SEM. (Top) P >
0.3 for all comparisons, which is not significant (ns). (Bottom) FO, *P = 0.028; MZ, ****P < 0.0001. (F) Flow cytometric analyses of peritoneal cavity B cells from
adult mice. (G) B cell numbers from peritoneal cavities as in F from at least nine mice of each genotype. Data are presented as mean ± SEM. B-1a and B-1b,
****P < 0.0001; B-2, P = 0.9, which is not significant (ns). (H) Flow cytometric analysis of PTIP-GFP expression in freshly isolated peritoneal cavity B cells.
(I) Mean PTIP-GFP expression intensities from B cells as in H relative to WT controls from four mice. PerC, B-2 vs. B-1b, **P = 0.009; B-2 vs. B-1a, **P = 0.01; SPL,
FO vs. MZ, ***P = 0.0005. Statistics were performed by using a two-tailed unpaired t test with Welch’s correction.
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pre-B cells to small quiescent pre-B cells at a developmental time
when Ig light-chain rearrangement is initiated in response to pre-B
cell receptor (BCR) signaling.
PTIP Deficiency Impairs Establishment of Innate-Like B Cells. Spleens
from PTIP−/− mice showed similar frequencies and numbers of
transitional (CD93+B220+) and mature (CD93−B220+) B cells
vs. control animals (Fig. 2 C and D), yet displayed a subtle 1.4-
fold decrease in FO B cells (Fig. 2 D and E). In contrast, we
observed a 4.7-fold decrease in the number of MZ B cells from
PTIP−/− mice (Fig. 2 D and E and Fig. S2 A–C). This observation
is intriguing, as MZ B cells contribute to TI IgM production (3)
and share with B-1 B cells a stronger dependency on BCR-
mediated signals for maturation and maintenance (3, 12, 13).
B-1 B cells largely reside in the peritoneal cavity and, in mice,
are divided into the CD5+ B-1a subset, which preferentially
mature during fetal and neonatal life, and the continuously
replenished CD5− B-1b subset. To determine whether the defect
in natural IgM production in PTIP−/−mice might be explained by
PTIP regulation of B-1 B cells, we analyzed peritoneal cavity cells
from PTIP−/− and control mice by FACS. Among CD19+IgM+
peritoneal cavity B cells, we observed severe reductions in the
frequencies and numbers of B-1a and B-1b cells (Fig. 2 F and G
and Fig. S2 D and E). Specifically, B-1a (CD19+IgM+CD5+
CD43+CD23−) cells were nearly absent and B-1b (CD19+IgM+
CD5−CD43+CD11b+CD23−) cell numbers were decreased by
9.6-fold compared with control mice (Fig. 2G). In stark contrast,
the numbers of conventional B (CD19+IgM+CD5−CD43−
CD11b−CD23+) cells in the peritoneal cavity were indistinguishable
vs. control mice (Fig. 2G). A similar decrease in B-1a cell numbers
was observed in the spleen (Fig. S2 A and F). Residual PTIP−/−
B-1a and B-1b cells exhibited alterations in their surface phenotype,
including lower expression levels of CD43 and CD11b (Fig. 2F);
moreover, surface expression of B220 (Fig. 2 A and C and Fig. S2G)
and CD23 (Fig. 2 E and F and Fig. S2B) were lower on conven-
tional B cells from PTIP−/− mice compared with controls. We
conclude that PTIP promotes the generation and/or maintenance of
innate-like B-1a and B-1b cells in unperturbed mice. Our observa-
tion of the concomitant decrease in B-1 and MZ B cell populations
in PTIP−/− mice likely explains the observed impairment in steady-
state as well as antigen-induced IgM production (Fig. 1).
To better understand the requirement for PTIP protein in
various B cell subsets, we measured PTIP expression at the
single-cell level by using a previously described knock-in mouse
model that expresses GFP-tagged PTIP under the control of its
endogenous regulatory elements (PTIPgfp/gfp) (6). Interestingly,
PTIP-GFP protein levels were higher in the B-1a, B-1b, and MZ
B cell populations compared with conventional B-2 cells (Fig. 2
H and I). Together with the GC defects, these results from
innate-like B cells are consistent with a functional requirement
for PTIP in cells that have a strong dependency on BCR-
mediated signals for maturation and maintenance.
PTIP Is Required for Neonatal B Cell Maturation. With B cell de-
velopment in the bone marrow only being mildly reduced, pos-
sibly leading to a slower establishment of mature conventional
B cell pools, the profound loss of B-1 cells and natural IgM in
mice lacking PTIP remained curious. To better understand the
reason for such immunodeficiency, we further investigated B-1a
cell maturation in greater detail. Shortly after birth, rapid ac-
cumulation of B-1a cells in the peritoneal cavity (Fig. 3A) co-
incides with the increase in total and PC-specific serum IgM
levels, as seen in 3-wk-old WT mice (Fig. 3 B and C). Strikingly,
only a negligible increase in B-1a cell numbers are found in
PTIP−/− peritoneal cavities throughout ontogeny, and natural
antibody titers remain flat-lined (Fig. 3 A–C and Fig. S3A).
B-1a cells are not efficiently generated in adult life and sustain
their peripheral presence through bone marrow-independent
self-maintenance (14). To assess if a maturation defect could
contribute to the observed decrease in B-1a cell representation
in PTIP-deficient mice, we analyzed transitional B cells from
spleens of neonatal mice known to efficiently give rise to B-1a B
cells (15). Compared with controls, spleens from 1-d-old neo-
natal PTIP−/− mice showed decreased frequencies of transitional
(CD93+B220+) B cells, including lower cell numbers of the three
distinct transitional stages: T1 (CD93+B220+IgM+CD23−), T2
(CD93+B220+IgM+CD23+), and T3 (CD93+B220+IgMloCD23−;
Fig. 3 D and E). Similar results were obtained for mature
(CD93−B220+) B cells, and results were also similar at 2 d of age
(Fig. 3 D–F). Remarkably, by 2 wk of age and later in adult mice
as described earlier (Fig. 2 C and D), these splenic B cell mat-
uration defects were no longer apparent (Fig. 3 D–F). A de-
velopmentally restricted neonatal CD5+ transitional B cell subset
(CD19+CD93+B220loIgM+CD5+) was recently identified that
predominantly gives rise to B-1a cells (16). We readily detected
the transient developmental wave of such CD5+ transitional B
cells in 2-d- to 2-wk-old control mice; however, consistent with a
defect in B-1a cell development, the percentage and absolute
number of CD5+ transitional B cells showed a marked decrease
in the absence of PTIP (Fig. 3 G and H). Moreover, PTIPgfp/gfp
mice showed higher PTIP protein levels in transitional B cells
from 3-d-old mice compared with mice at 5 or 12 wk of age (Fig.
3I), coinciding with the peak of B-1a cell output during ontog-
eny. These results collectively demonstrate a reliance on high
PTIP expression during neonatal B lymphopoiesis, consistent
with a requirement for PTIP for the output of B-1a cells and
natural IgM levels.
PTIP-Deficient B-1a Cells Are Unable to Maintain Long-Term Survival
of Self-Reactive Clones. B-1a cells are enriched for self-reactive
specificities and rely mainly on self-antigen driven survival to
maintain their peripheral population through life (12). The most
common BCR specificity among B-1a cells is directed toward the
self-glycolipid phosphatidylcholine (PtC) (17, 18) exposed on the
surface of damaged cells. In light of the observed defects in
neonatal B-1a cell development, we sought to understand
whether the failure of B-1a cells to accumulate and establish a
sizable population in PTIP-deficient mice is a consequence of an
inability to produce a self-reactive BCR repertoire. To this end,
we performed high-throughput Igh-μ repertoire analysis by
(variable, diversity, joining) deep sequencing (VDJ-Seq) of the
residual peritoneal cavity B-1a cell populations in 5- and 8-wk-old
PTIP−/− mice (as shown in Fig. 2F and Fig. S3A). Upon extraction
of the identities and frequencies of CDR3 clonotypes, we found the
B-1a repertoire of 5-wk-old PTIP−/− mice to harbor comparable
frequencies of PtC-reactive CDR3s vs. age-matched controls (Fig.
4 A and B and Fig. S3B). This result demonstrates that bona fide B-
1a specificities can be generated in the absence of PTIP. Strikingly,
the representation of this specificity is markedly decreased in 8-wk-
old PTIP−/− mice, evident by a trend toward decreased usage of
the VH12 segment known to encode the PtC specificity and an
increased usage of VH4 (Fig. 4 A–C). Thus, although PTIP-
deficient mice can successfully generate a small number of B-1a
cells with the appropriate self-reactive BCR specificities, these
clones fail to be maintained through self-antigen driven positive
selection. Thus, the apparent lack of B-1a cells in adult PTIP−/−
mice may be a compound effect from defects in B-1a cell matu-
ration (Fig. 3) and peripheral maintenance.
To establish a direct role of PTIP in mature B-1a cell survival
and maintenance in vivo without the influence of bone marrow
influx, we FACS sorted PTIP−/− and control B-1a cells from
5-wk-old mice and transplanted equal numbers intraperitoneally
into RAG1−/− recipient mice. Two weeks after transplantation,
markedly fewer B cells remained in recipients of PTIP−/− cells
compared with controls (Fig. 4D). This survival defect could be
recapitulated upon in vitro culturing in media, in which PTIP−/−
Su et al. PNAS | Published online October 16, 2017 | E9331
IM
M
U
N
O
LO
G
Y
A
N
D
IN
FL
A
M
M
A
TI
O
N
PN
A
S
PL
U
S
2 3 4 6 9
0
50
100
150
200
0
200
400
600
BA
0
50
100
150
200C
µµ
I
0
25
50
75
100
125
***
****
0
30
60
90
120
G
0
1
2
3
4
5
0
2
3
F
T1 T2 T3 mature B
0
5
10
15
20
25
D E
***
*
*
*
T1 T2 T3 mature B
0
200
400
600
800
1000
H
Fig. 3. PTIP is required for neonatal B cell maturation and the establishment of serum natural IgM levels. (A) B-1a cell numbers at the indicated age (in
weeks) after birth. Data are from at least three mice for each age and genotype and are represented as mean ± SEM. (B and C) ELISA analysis of anti-PC IgM
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pooled from at least five mice of each genotype. (F) Flow cytometric analysis of BCL2 intracellular expression in B-1a cells from peritoneal cavities of 5-wk-old
mice. (Left) Representative plot and (Right) mean expression intensities from at least three mice of each genotype (**P = 0.004). (G) Flow cytometric analysis
of peritoneal cavity YFP+ IgM+CD19+ B cells from mice 4 wk after TAM administration. (Bottom) Skewing of CD43 expression on CD5+ B-1a cells in the mutant.
Representative from multiple mice. Note the labeling of the PTIPΔ/Δ genotype, abbreviated from Cre-ERT2+Rosa26YFP/YFPPTIPflox/flox, in which YFP is expressed
(as a marker of Cre recombinase expression) upon TAM administration to the mice. WT mice have genotype Cre-ERT2+Rosa26YFP/YFPPTIP+/+ and were ad-
ministered TAM in parallel (statistics are shown in Fig. S4). (H) B cell frequencies within the YFP gate from peritoneal cavities of three mice of each genotype
1 wk after TAM administration. Data are presented as mean ± SEM. YFP+ B-1a, PTIPΔ/Δ vs. WT [**P = 0.008; for other comparisons, P > 0.05, not significant
(ns)]. (I) B-1a cell frequencies within the YFP gate displaying reactivity to Vh12 (Left) or PtC liposomes (Right) from peritoneal cavities from at least six mice of
each genotype 4 wk after TAM administration. Data are presented as mean ± SEM. YFP+ Vh12+, PTIPΔ/Δ vs. WT (*P = 0.029); YFP− Vh12+, PTIPΔ/Δ vs. WT [P = 0.6,
not significant (ns)]. YFP+ PtC liposome+, PTIPΔ/Δ vs. WT (**P = 0.003); PTIPΔ/Δ PtC liposome+, YFP+ vs. YFP− (**P = 0.01); YFP− PtC liposome+, PTIPΔ/Δ vs. WT [P =
0.3, not significant (ns)]. (J) Mean BCL2 intracellular expression intensities in peritoneal cavity B-1a cells from four mice of each genotype 4 wk after TAM
administration. YFP+, PTIPΔ/Δ vs. WT (*P = 0.04). Data representative of two independent experiments. Statistics were obtained by using a two-tailed unpaired
t test with Welch’s correction.
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B-1a cells from 5-wk-old mice were found to have a reduced fre-
quency of live Annexin V−DAPI− cells after 48 h (Fig. 4E). Con-
sistent with these results, we measured the expression of the
antiapoptotic BCL2 gene and found it to be significantly reduced at
the mRNA and protein levels in PTIP−/− B-1a cells compared with
controls (Fig. 4F and Fig. S4A). We conclude that PTIP promotes
B-1a cell survival and is associated with increased BCL2
expression.
To formally rule out any developmental influence on B-1a cell
survival, we crossed PTIPflox/floxmice with a mouse strain expressing
tamoxifen (TAM)-inducible Cre-ERT2 to assess the effects of TAM-
induced deletion of PTIP expression. In adult mice, bone marrow-
dependent influx into the B-1a compartment is low; therefore, any
observed phenotypes in the immediate weeks following TAM treat-
ment of adult mice can be attributed to changes in the functionality
of mature B-1a cells rather than developmental consequences. To
visualize the frequency of Cre recombinase-expressing cells in these
mice, we crossed in the Rosa26-stop-YFP Cre-reporter allele to
generate Cre-ERT2+Rosa26YFP/YFPPTIPflox/flox (herein referred to as
PTIPΔ/Δ) and control mice (Cre-ERT2+Rosa26YFP/YFPPTIP+/+, herein
referred to as WT). Upon validating efficient Cre-mediated
deletion (Fig. S4 B–D), we observed that several in vivo phe-
notypes of PTIP−/− mice were also recapitulated following in-
ducible PTIP deletion. First, a significant decrease in the
frequency of B-1a but not B-2 B cells could be observed among
YFP+ peritoneal cavity cells of PTIPΔ/Δ mice after TAM ad-
ministration (Fig. 4 G and H and Fig. S4E). Second, within the
B-1a cell gate, frequencies of VH12+ and PtC liposome+ cells
were decreased in YFP+ cells of PTIPΔ/Δ mice (Fig. 4I and Fig.
S4F), consistent with PTIP being required for self-antigen driven
peripheral maintenance (Fig. 4 A–C). Finally, YFP+ B-1a cells
from treated PTIPΔ/Δ mice displayed decreased BCL2 expres-
sion compared with controls (Fig. 4J and Fig. S4G). Taken
together, these results formally establish a crucial role for PTIP
in the survival of adult B-1a cells that is distinct from any de-
velopmental effects of PTIP deficiency.
PTIP Is Required for B Cell Activation via the NF-κB Pathway. To
elucidate the molecular function of PTIP, we subjected sorted
B-1a cells from 5-wk-old PTIP−/− and control animals to
microarray-based global analyses of gene expression changes. In
total, PTIP-deficient B-1a cells revealed 137 genes whose ex-
pression was down-regulated and 78 genes whose expression was
up-regulated by at least twofold (Dataset S1). Interestingly, many
differentially expressed genes were associated with signal trans-
duction in the immune system, indicative of a role for PTIP in
regulating signaling events (Fig. 5A). To further investigate this
notion, we screened for the expression of a panel of proteins
known to play a role in B-1a cell signaling by FACS. Although
many of these did not change (CD19, BAFFR, and IL5RA; Fig.
S5A), a few notable proteins were differentially expressed in the
absence of PTIP. These include decreased Ceacam1/CD66a (Fig.
5B) and FcγRIIB (Fig. S5A), which were identified by the
microarray, as well as increased CD72 (Fig. 5C) and CD22, and
decreased CD43 and Siglec-G (Fig. S5A). Notably, Ceacam1 pro-
motes signaling through the canonical NF-κB pathway (19),
whereas CD72 can oppose it (20). Furthermore, the microarray
identified an increase in the mRNA levels of Anxa1, encoding
Annexin A1, a negative regulator of canonical NF-κB signaling (21,
22) (Dataset S1). Increased Annexin A1 was validated at the
protein level by intracellular FACS in B-1a, B-1b, and B-2 B cells
(Fig. 5D). These findings are intriguing in lieu of the crucial role of
the NF-κB pathway in promoting B-1 and MZ B cell development
as well as B cell survival through the regulation of Bcl2 family
members (23, 24). To further investigate a potential role of PTIP in
NF-κB signaling, we measured the expression of NF-κB proteins in
freshly isolated PTIP−/− B-1a cells from 5-wk-old mice. These
analyses revealed decreased intracellular levels of cREL (Fig. 5 E
and F) along with NF-κB targets urokinase plasminogen activator
(uPA) and IRF4 (Fig. S5A), suggesting that the absence of PTIP
may perturb the classical NF-κB pathway and thereby lead to the
observed impairments in the B-1 population.
The molecular program of steady-state B-1 cells often shares
characteristics with that of their activated FO B-2 counterparts (2).
Thus, we hypothesized that, even though PTIP only subtly reduces
FO B-2 numbers at steady state (Fig. 2 D and E), it may regulate
their function upon activation. Consistent with this notion, we found
PTIP protein expression in mature splenic B cells cultured for 3 d to
be increased 2.5-fold, 3.6-fold, or 5.2-fold upon anti-CD40, LPS, or
BCR cross-linking, respectively, by using PTIPgfp/gfp mice (Fig. 5G
and Fig. S5B). To directly assess the role of PTIP in BCR-induced
FO B-2 B cell activation, we first measured cell proliferation by way
of carboxyfluorescein N-hydroxysuccinimidyl ester (CFSE) dilution.
Strikingly, proliferation of PTIP−/− splenic B cells was entirely ab-
rogated in response to stimulation with anti-IgM antibody (Fig. 5H
and Fig. S5C), with fewer cells undergoing active DNA replication
as measured by EdU incorporation (Fig. S5D). An impairment in
proliferation was also observed in PTIP−/− B cells in response to
anti-CD40 (Fig. 5H and Fig. S5C). Interestingly, LPS and the
TLR9 ligand CpG oligonucleotide stimulations induced extensive
proliferation in WT and PTIP−/− B cells, although the fraction of
B cells that underwent activation-induced proliferation was subtly
decreased in the absence of PTIP (Fig. 5H and Fig. S5 C and D).
Survival of PTIP−/− B cells was reduced by 2.4-fold upon stimu-
lation with anti-IgM antibody but was less affected in response to
other stimulations (Fig. S5E). Together, these data suggest that
PTIP is required for specific aspects of B-2 cell activation down-
stream of antigen- and T:B interaction-induced activation rather
than general cell cycle progression. Consistent with this notion,
stimulated PTIP−/− B cells showed reduced cell surface expression
of the CD86 activation marker in vitro and in vivo following anti-
IgM stimulation and SRBC immunization, respectively (Fig. S6 A
and B). These results indicate a crucial role for induced PTIP protein
levels in propagating molecular events downstream of BCR ligation.
To identify signaling pathways that might be altered in PTIP-
deficient FO B-2 B cells, we performed intracellular FACS
analyses for phosphorylation events triggered by BCR cross-
linking. We found no differences with respect to phospho-S6
(Fig. S6C), phospho-ERK (Fig. S6D), phospho-JNK (Fig. S6E),
or phospho-SYK (Fig. S6F), consistent with normal membrane-
proximal signaling and activation of the PI3K/AKT/mTOR and
MAPK pathways. We did, however, detect significantly de-
creased protein expression of cREL (Fig. 5I and Fig. S6G) and
the NF-κB target genes NFATc1, BCLXL, and BCL2 in PTIP−/−
B cells (Fig. S6 G and H). These results constitute further evi-
dence that the classical NF-κB pathway is impaired in the ab-
sence of PTIP. Consistent with these data, we observed elevated
levels of IκBα in both freshly isolated and anti-IgM-stimulated
FO B-2 B cells from PTIP−/− mice (Fig. S6I). The classical and
the alternative NF-κB pathways are activated in B cells when
stimulated with anti-CD40 antibody (25, 26). To determine
whether PTIP also regulates the alternative NF-κB pathway, we
interrogated the expression of RELB and its target gene PIM2 in
anti-CD40 stimulated PTIP−/− and control B cells. Although we
again observed decreased cREL expression, RELB and PIM2 were
unchanged (Fig. 5J and Fig. S6J). Altogether, these results dem-
onstrate a requirement for PTIP in promoting signaling via the
classical NF-κB pathway in steady-state B-1a cells and FO B-2 B
cells in response to BCR or CD40 engagement, providing an ex-
planation for the apparent lack of postimmune antibody and GC
responses upon TI and TD immunizations (Fig. 1).
Discussion
In this study, we use mouse genetics to establish a crucial role for
PTIP in licensing the humoral arm of the adaptive immune
system in vivo, through regulating key activation and signaling
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Fig. 5. PTIP is required for B cell activation via the NF-κB pathway. (A) Canonical pathways and biological processes overrepresented in the genes
deregulated from microarray analysis of PTIP−/− relative to control-sorted B-1a cells from 5-wk-old mice. (B–E) Flow cytometric analysis of Ceacam1 (B) and
CD72 (C) surface expression and Annexin A1 (D) and cREL (E) intracellular expression in B cells from peritoneal cavities of 5-wk-old mice. (Left) A repre-
sentative plot from B-1a cells. (Right) Mean expression intensities in peritoneal cavity B cells from at least four mice of each genotype. (B) B-1a (****P <
0.0001); B-1b (**P = 0.002); B-2 (***P = 0.001). (C) B-1a (**P = 0.007); B-1b (**P = 0.002); B-2 [P = 0.47, not significant (ns)]. (D) B-1a (****P = 0.0001); B-1b
(***P = 0.001); and B-2 (****P < 0.0001). (E) B-1a (**P = 0.003); B-1b [P = 0.16, not significant (ns)]; B-2 (*P = 0.03). (F) Flow cytometric analysis of cREL
intracellular expression in B-1a cells from spleens of 5-wk-old mice. (Left) Representative plot. (Right) Mean expression intensities in splenic B cells from four
mice of each genotype (*P = 0.018). Statistics were obtained by using a two-tailed unpaired t test with Welch’s correction. (G) Flow cytometric mean PTIP-GFP
expression intensities in splenic B cells relative to WT controls from two adult mice after 3 d of the indicated stimulation. (H) Flow cytometric analysis of CFSE-
labeled splenic B cells with or without the indicated stimulation for 3 d. (I) Flow cytometric analysis of cREL intracellular expression in splenic B cells stimulated
with anti-IgM for 18 h. (J) Flow cytometric analysis of cREL intracellular expression in splenic B cells stimulated with anti-CD40 for 24 h. (H–J) Representatives
from multiple mice 7–8 wk of age, with statistics shown in Fig. S5.
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events critical for multiple aspects of B cell development and
function (Fig. 6). By using a PTIP-GFP knock-in mouse model,
we demonstrate that cellular levels of PTIP protein correlate
with BCR signaling strength, being elevated in steady-state
innate-like B cell subsets and stimulated FO B cells. By using
mice that lack PTIP in a B cell-specific manner, we show a partial
block in B cell development at the pre-B cell stage, a severe
impairment in neonatal B-1a cell maturation, and defective GC
B cell differentiation. In addition, we find that sustained PTIP
expression in adult mice is required to promote the long-term
maintenance of bona fide self-reactive B-1a cells. Although the
steady-state numbers of splenic B-2 cells are not markedly re-
duced in PTIP-deficient mice, these cells fail to undergo BCR or
CD40 stimulation-induced proliferation, at least in part, because
of a defect in the classical NF-κB pathway. These results significantly
expand the list of PTIP-dependent B cell functions beyond pro-
moting sterile transcription at the Igh locus and CSR (6, 8, 9) and
indicate a key role for PTIP in activation-associated proliferation,
survival, and differentiation triggered by antigen engagement and
T:B interaction. Consequently, PTIP deficiency results in severe
hypo-IgM, hypogammaglobulinemia, and profoundly blunted anti-
body responses to TD and TI antigen immunization, hallmarks of
primary common variable immunodeficiency (CVID).
Although the precise molecular targets by which PTIP medi-
ates its function in B cell signaling remain to be elucidated, we
provide multiple lines of evidence in PTIP-deficient B-1a cells
and activated B-2 B cells for deregulation of the classical NF-κB
pathway. In addition to decreased cREL and increased IκBα at
steady state and in response to anti-IgM, we find protein levels of
a handful of NF-κB target genes to be decreased in PTIP-deficient
B cells, including BCL2, BCLXL (27, 28), NFATc1 (29), uPA,
IRF4 (30), and CD23 (31). These findings indicate a requirement
for PTIP in the classical NF-κB pathway and are in line with (i) the
established role of the NF-κB pathway in B-1 cell development (15,
24, 25, 32), (ii) evidence for a role of NF-κB downstream of pre-
BCR signaling in small pre-B cells (28, 33–36), and (iii) FO B-2 cell
functionality including activation-induced proliferation, survival,
antibody production, GC differentiation, and CSR (24–26, 37).
Although the role of NF-κB signaling in the development of FO B
cells may primarily be to promote BCL2 or BCLXL expression for
antiapoptotic effects (27, 28, 34), evidence suggests that BCL2-
independent functions of NF-κB play a major role in B-1, MZ,
and GC B cells and hint at prominent roles during activation-
associated differentiation (24, 27, 37). Considering that the cREL
NF-κB protein plays an important role in antigen-mediated BCR
activation (38) and that sustained cREL activation in response to
BCR signaling requires de novo cREL transcription (39), we
speculate that PTIP may function in the activation and/or expres-
sion of this protein. Several other PTIP-regulated genes have also
previously been shown to influence the NF-κB pathway including
CD72 (20, 40), Ceacam1 (19), and Annexin A1 (21, 22). Future
studies aimed at determining the contribution of each of these
signaling components to the various junctures of PTIP involvement
in B cell biology (Fig. 6) will be needed to map the PTIP-dependent
genetic program establishing humoral immunity.
The striking lack of steady-state levels of serum IgM in PTIP-
deficient mice despite normal numbers of overall splenic B cells
correlates with the combined loss of B-1 and MZ B cells. These
innate-like B cell subsets act in concert to mediate the majority
of TI antibody production (2–4), and their development differs
from FO B-2 cells in their increased dependency on BCR sig-
naling. For example, B-1a and MZ B cells are positively selected
on self-antigen during maturation and their unique clonal rep-
resentation depends on continued self-antigen exposure (12, 13,
17). Indeed, numerous mouse models deficient in B-1 cells show
concomitant defects in MZ B cells (3, 25), including those har-
boring perturbations in BCR signaling and the NF-κB pathway.
We speculate that the B-1 and MZ B cell defects associated with
PTIP deficiency stem from a common impairment in signaling
and manifest together as a general reduction in natural and
postimmune IgM levels. Furthermore, the aforementioned
characteristics of innate-like B cells along with the observed
higher PTIP protein levels in B-1 and MZ B cells compared with
FO B cells are consistent with PTIP protein expression being
positively regulated by BCR signaling. Similarly, the elevated
expression of and reliance on PTIP protein during neonatal B
lymphopoiesis hint toward elevated BCR signaling early in life.
PTIP is a multifunctional chromatin regulator known to dy-
namically contribute to several multimeric protein complexes to
regulate transcription and DNA repair in response to changes in
cellular demand (5). A common denominator for our observed
PTIP functions in humoral immunity, including the previously de-
scribed regulation of sterile transcription at the Igh locus (6, 8), is that
they operate independently from its interaction with the 53BP1DNA
repair protein. Consistent with this, perturbations of other DNA
damage response factors do not impact steady-state or postimmune
IgM responses. Moreover, B cells lacking PTIP do not have an in-
herent defect in cell cycle progression. Thus, we speculate that PTIP-
dependent transcriptional regulation rather than its involvement in
DNA repair/replication is responsible for the observed effects on
humoral immunity. Although MLL4 complexes containing PTIP
have been shown to regulate B cell gene expression, phenotypic
differences between PTIP- andMLL4-deficient mice (6, 41, 42) point
toward an MLL4-independent role for PTIP in humoral immunity.
Although much remains to be understood about how
PTIP is regulated by, and in turn regulates, BCR and T:B
interaction-triggered molecular events, a model is emerging in
which PTIP fundamentally controls humoral immunity at
multiple junctures of B cell development and differentiation
Fig. 6. Model showing multiple points of PTIP involvement in B cell activation-
associated proliferation/differentiation for licensing humoral immunity. PTIP
regulates multiple aspects of B cell development and function including (i) the
development of B-1 B cells in neonatal life and their self-renewal/survival in
adult life, contributing to natural IgM levels in serum before antigen stimula-
tion; (ii) efficient differentiation of small pre-B cells in response to pre-BCR
signaling during B cell development; (iii) facilitating signal transduction in re-
sponse to BCR engagement to promote B cell activation and proliferation/sur-
vival, contributing to TI production of antigen-specific IgM during the initial
phase of the antibody response; (iv) facilitating signal transduction in response
to CD40/CD40L engagement to promote B cell activation and proliferation
upon cognate T cell-B cell interaction including GC B cell differentiation; and
(v) activating sterile transcription at “switch regions” within the Igh locus to
promote IgG class-switching. Ag, antigen; Prog, progenitor; TH, helper T cell.
Gray dots signify self-antigens; red dots signify foreign antigens.
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(Fig. 6). Our results place PTIP in a molecular node required
for B cell activation important for humoral immune responses
in health and disease. CVID is the most prevalent primary
antibody deficiency; with a highly heterogeneous disease ori-
gin, the genetic abnormality remains unknown in a majority of
patients (43). Further work investigating the mechanism of
PTIP function in this context and how it controls the NF-κB
pathway may generate valuable new insight.
Materials and Methods
Bone marrow and spleens were subjected to RBC lysis. Antibodies are de-
tailed in Table S1. FACS experiments on freshly isolated cells used a DAPI
negative live lymphocyte gate. Intracellular staining experiments used the
Zombie Aqua fixable viability kit (BioLegend). Cells were acquired on BD
LSRFortessa and sorted on a BD FACSAria III Cell Sorter. All other methods
are described in SI Materials and Methods.
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